Nova Biomedical

Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,400 people, with sales and service subsidiaries in eight countries and distributors in more than 91 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts; and Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.

Showing the single result

Nova Biomedical – BioProfile FLEX2 Analyzer
Automated Cell Culture Analyzer With Maintenance-Free Chemistry Sensors

BioProfile FLEX2 combines Nova’s groundbreaking MicroSensor™ Card technology with optical measurement and freezing point osmome...

Automated Cell Culture Analyzer With Maintenance-Free Chemistry Sensors

BioProfile FLEX2 combines Nova’s groundbreaking MicroSensor™ Card technology with optical measurement and freezing point osmometry for an automated and comprehensive cell culture analyzer that eliminates chemistry sensor maintenance, increases analyzer speed, and reduces sample volume. The full 16 cell culture test menu includes: Gluc, Lac, Gln, Glu, NH4+, Na+, K+, Ca++, pH, PCO2, PO2, total cell density, viable cell density, viability, cell diameter, and osmolality.

Compared to the previous generation BioProfile FLEX there is no maintenance for any of the 11 chemistry and gas sensors, sample volume for the full test menu is reduced by 75% to 275 microliters, and testing time is reduced to just 4.5 minutes. Automated sampling from 96-well plates, syringes, or a 24-position external “load-and-go” sample tray provides maximum workflow flexibility and efficiency for cell culture monitoring.

Read more